SCM Lifescience Co., Ltd.
Develops high-purity stem cell therapies for incurable immunological and inflammatory diseases.
298060 | KO
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- South Korea
- Address:
- 인천광역시 연수구 갯벌로145번길 7-7 (송도동, 에스씨엠생명과학(주)), 인천광역시
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
SCM Lifescience Co., Ltd. is a biotechnology company dedicated to developing high-efficacy cell therapies for incurable diseases. The company specializes in next-generation allogeneic and mesenchymal stem cell (MSC) therapeutics. Its core competency lies in its proprietary Subfractionation Culturing Method, a source technology for isolating and culturing high-purity, high-potency stem cells. The R&D pipeline focuses on treating immunological and inflammatory conditions, such as graft-versus-host disease and atopic dermatitis. The company's strategy includes global expansion through mergers and acquisitions, fostering open innovation in iPSC and tissue engineering, and developing cost-effective mass production capabilities with 3D bioreactor technology.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-17 00:00 |
M&A Activity
주요사항보고서(회사합병결정)
|
Korean | 93.1 KB | ||
| 2025-09-17 00:00 |
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
|
Korean | 4.7 KB | ||
| 2025-09-15 00:00 |
Share Issue/Capital Change
증권발행결과(자율공시) (제1회차 CB)
|
Korean | 6.2 KB | ||
| 2025-09-15 00:00 |
M&A Activity
합병등종료보고서(자산양수도)
|
Korean | 15.4 KB | ||
| 2025-09-08 00:00 |
Share Issue/Capital Change
주요사항보고서(유상증자결정)
|
Korean | 47.9 KB | ||
| 2025-09-08 00:00 |
Capital/Financing Update
주요사항보고서(전환사채권발행결정)
|
Korean | 59.2 KB | ||
| 2025-09-05 00:00 |
M&A Activity
주요사항보고서(타법인주식및출자증권양수결정)
|
Korean | 34.0 KB | ||
| 2025-09-05 00:00 |
Share Issue/Capital Change
주요사항보고서(전환사채권발행결정)
|
Korean | 51.5 KB | ||
| 2025-09-02 00:00 |
Major Shareholding Notification
[기재정정]주식등의대량보유상황보고서(일반)
|
Korean | 147.7 KB | ||
| 2025-09-02 00:00 |
Major Shareholding Notification
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 52.5 KB | ||
| 2025-09-01 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 85.3 KB | ||
| 2025-09-01 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.2 KB | ||
| 2025-08-14 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 1.4 MB | ||
| 2025-08-14 00:00 |
Capital/Financing Update
타인에대한담보제공결정
|
Korean | 20.2 KB | ||
| 2025-08-08 00:00 |
Capital/Financing Update
타인에대한담보제공결정
|
Korean | 19.4 KB |
Automate Your Workflow. Get a real-time feed of all SCM Lifescience Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for SCM Lifescience Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
